FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
FNCH
Delisted
FNCH was delisted on the 24th of May, 2024.
43 hedge funds and large institutions have $16.8M invested in Finch Therapeutics Group, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
43
Holding in Top 10
2
Calls
–
Puts
$2K
Top Buyers
| 1 | +$423K | |
| 2 | +$178K | |
| 3 | +$49.9K | |
| 4 |
VF
Virtu Financial
New York
|
+$25K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$18.8K |
Top Sellers
| 1 | -$155K | |
| 2 | -$104K | |
| 3 | -$70K | |
| 4 |
Morgan Stanley
New York
|
-$33.1K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$29K |